IP Library Granted Patent US 11,696,969
Granted Patent B2
US 11,696,969 · App. 16/078,749 · Granted Jul 11, 2023

Ethylene oxide treatment indicator, label and method of use

Inventor: Peter James Tatnell (Cardiff, GB)
Assignee: Global Life Sciences Solutions Operations UK Ltd
A61L2/28A61L2/206G01N31/226A61L2202/23A61L2202/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,696,969
App. No.
16/078,749
Granted
Jul 11, 2023
Kind
B2
Abstract

The present invention provides an indicator useful in confirming successful sterilisation and/or nucleic acid decontamination by ethylene oxide (EtO) treatment. The invention also provides a label comprising said indicator and methods for use of the indicator and label in a method of EtO treatment.

Claims (26)

1. A method to confirm successful EtO exposure wherein said method comprises:

(a) exposing an article to EtO for a defined period of time wherein said article comprises an indicator;

(b) inspecting a colour of said indicator following step (a);

wherein said indicator comprises a solid support, a dye, and one or more nucleic acid stabilization chemicals, wherein said one or more nucleic acid stabilisation chemicals comprises a chaotrope, wherein the solid support is treated with the dye to form a chemical bond between the dye and the solid support, wherein the dye is selected from the group consisting of—

(i) Bromophenol Red,

(ii) Bromocresol Purple,

(iii) Bromothymol Blue,

(iv) Bromoxylenol Blue,

(v) Chlorophenol Red,

(vi) m-Cresol Purple,

(vii) Cresol Red,

(viii) Neutral Red,

(ix) Nitrazine Yellow,

(x) Rosolic Acid,

(xi) Mordant Blue 9, and

(xii) Ruthenium Red.

2. The method as defined in claim 1 , wherein said solid support is selected from the group consisting of cellulose based paper and woven or non-woven fibrous materials, including man made, or naturally occurring polymer fibres or mineral fibre based materials.

3. The method as defined in claim 1 , wherein said solid support is a cellulose based paper.

4. The method as defined in claim 1 , wherein said solid support comprises more than one of said dyes.

5. The method as defined in claim 1 , wherein said nucleic acid stabilisation chemicals further comprise a nucleic acid stabilisation chemical selected from the group consisting of a weak base, a chelating agent, an anionic surfactant, and an anti-oxidant.

6. The method as defined in claim 1 , wherein said chaotrope is a guanidinium salt.

7. The method as defined in claim 1 , wherein said article further comprises a label for attachment to said article intended for EtO treatment, wherein said label comprises (i) the indicator and (ii) means to fix said indicator to said article.

8. The method as defined in claim 1 , wherein said defined period of time is 3-6 hours.

9. The method as defined in claim 1 , wherein said defined period of time is effective for nucleic acid decontamination.

10. The method as defined in claim 9 , wherein said article is the indicator.

11. The method as defined in claim 1 , wherein said defined period of time is effective to sterilise said article.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2020
From: GE HEALTHCARE UK LIMITED
To: GLOBAL LIFE SCIENCES SOLUTIONS OPERATIONS UK LTD
Reel/Frame 053653/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2018
From: TATNELL, PETER JAMES
To: GE HEALTHCARE UK LIMITED
Reel/Frame 046660/0073 →